Treatment response measurements and survival outcomes in a cohort of newly diagnosed AL amyloidosis.

Victor H Jimenez-ZepedaHolly LeeSylvia McCullochJason TayPeter DugganPaola NeriNizar Bahlis

Published in: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2021)

Our study suggests that maximal sFLC response and CR are potential endpoints to define clinical outcomes. Large collaborative studies are required to validate and optimize response criteria.

Keyphrases

newly diagnosed
heart rate
multiple myeloma
blood pressure
case control
human health
high intensity